Double-blind, Randomized, Placebo-controlled Pilot Study With Anapsos In Senile Dementia: Effects On Cognition, Brain Bioelectrical Activity And Cerebral Hemodynamics

Effect Increase
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 45
Sex Both Genders
Age Range 65+
Notes for this study:
In older adults with senile dementia, 360mg anapsos (but not 720mg nor placebo) was associated with improvements in cognition as assessed by ADAD-cog and was further associated with improvements in blood flow (both hemispheres with 360mg, only in the left with 720mg).